Webinar: Overview of BWXT Medical’s Licence Application
Join us for this webinar that will look at the regulatory review process for BWXT Medical’s application for a Class IB nuclear substance processing facility licence. BWXT Medical Ltd. (formerly BWXT ITG Canada, Inc.) has applied for this licence in order to operate a medical isotope facility at the Nordion campus in Ottawa, Ontario.
This is your opportunity to learn more about the application and how you can intervene at the June 9–10 public Commission hearing.
- Information on the BWXT Medical Inc. licence application
- How the CNSC regulates nuclear facilities
- CNSC licensing and compliance process
- How the public can participate in the upcoming Commission hearing (June 9–10) on the application
How to register
Space is limited, so please register in advance by clicking on the Webinar registration link below.
|Webinar topic||Date and time||Webinar summary||Deadline for registration|
|BWXT Medical’s Licence Application||April 8
1 pm EDT
|A look at the regulatory review process for BWXT Medical’s licence application for a Class IB nuclear substance processing facility licence||April 7, noon (EDT)|
Have a question in advance?
The CNSC welcomes questions prior to the webinar above. These may be addressed during or after the session.Submit your question
- Date modified: